[HTML][HTML] Turning the spotlight to cholinergic pharmacotherapy of the human language system
G Dávila, MJ Torres-Prioris, D López-Barroso… - CNS drugs, 2023 - Springer
Even though language is essential in human communication, research on pharmacological
therapies for language deficits in highly prevalent neurodegenerative and vascular brain …
therapies for language deficits in highly prevalent neurodegenerative and vascular brain …
Lower cerebral blood flow predicts cognitive decline in patients with vascular cognitive impairment
M van Dinther, AM Hooghiemstra, EE Bron… - Alzheimer's & …, 2024 - Wiley Online Library
INTRODUCTION Chronic cerebral hypoperfusion is one of the assumed pathophysiological
mechanisms underlying vascular cognitive impairment (VCI). We investigated the …
mechanisms underlying vascular cognitive impairment (VCI). We investigated the …
RAGE: a potential target for Epimedium's anti-neuroinflammation role in vascular dementia—insights from network pharmacology and molecular simulation
P Yuan, W Chen, X Wang, L Li, Z Peng… - Journal of …, 2023 - Taylor & Francis
Vascular dementia (VaD), a cognitive impairment resulting from cerebrovascular issues,
could be mitigated by Epimedium. This study investigates Epimedium's efficacy in VaD …
could be mitigated by Epimedium. This study investigates Epimedium's efficacy in VaD …
Association of the LIfestyle for BRAin Health Score and Brain Vascular Damage in a Community-Dwelling Adults Cohort
H Li, Q Zhou, X Cai, Y Wang, Y Yang, S Wang, X Meng… - medRxiv, 2023 - medrxiv.org
Objective To investigate the association of brain vascular damage and the LIfestyle for
BRAin Health (LIBRA) dementia risk scores. Methods This cross-sectional study was based …
BRAin Health (LIBRA) dementia risk scores. Methods This cross-sectional study was based …
A Longitudinal Study on Memory Enhancement in Subjective Cognitive Decline Patients: Clinical and Neuroimaging Perspectives
S Na, C Lee, SH Ho, YJ Hong… - Journal of …, 2023 - content.iospress.com
Background: Subjective cognitive decline (SCD) refers to the self-reported persistent
cognitive decline despite normal objective testing, increasing the risk of dementia compared …
cognitive decline despite normal objective testing, increasing the risk of dementia compared …
[PDF][PDF] 主观认识下降转归为阿尔茨海默病的研究现状
王慧娟， 李霞 - 实用老年医学, 2024 - sylnyx.com
AD 是一种常见的老年人慢性神经退行性疾病, 目前尚无特效疗法能阻止或逆转其病情进展.
主观认知下降(subjective cognitive decline, SCD) 近年来被认为是AD 的临床前期症状 …
主观认知下降(subjective cognitive decline, SCD) 近年来被认为是AD 的临床前期症状 …
Turning the spotlight to cholinergic pharmacotherapy of the human language system
MG Dávila-Arias, MJ Torres-Prioris, D López-Barroso… - 2023 - riuma.uma.es
Even though language is essential in human communication, research on pharmacological
therapies for language deficits in highly prevalent neurodegenerative and vascular brain …
therapies for language deficits in highly prevalent neurodegenerative and vascular brain …
Deterioro cognitivo subjetivo y sintomatología depresiva: relación con marcadores de patología neurodegenerativa, cognición y otros factores.
N Figueroa Lamas - 2023 - riull.ull.es
En general el deterioro cognitivo subjetivo (DSC) ha sido entendido como un marcador
temprano de la enfermedad de Alzheimer (EA), si bien en los últimos años se ha resaltado …
temprano de la enfermedad de Alzheimer (EA), si bien en los últimos años se ha resaltado …